Pharmacological rescue of follicle-stimulating hormone receptor mutants. In vitro and in silico studies
Endocrinology · 07.04.2026 · 167 (5)
DOI: 10.1210/endocr/bqag045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 16.04.2026. Verfasst von Teresa Zariñán und 6 weiteren Autor:innen. Beteiligte Einrichtung: Red de Apoyo a la Investigación (RAI), National University of Mexico, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: Receptors, FSH, Primary Ovarian Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM, Mexico, Coordinación de la Investigación Científica (CIC), UNAM, Mexico, Nanomaterials and Molecular Biophysics academic area of UAM-Lerma.
Abstract (Originalsprache)
Mutations in the follicle-stimulating hormone receptor (FSHR) may result in impaired plasma membrane expression due to misfolding and intracellular retention of the receptor, leading to disease. Rescue of misfolded receptors may be achieved employing pharmacological chaperones (small molecules that specifically bind misfolded proteins, promoting their correct trafficking to their site of action). This study analyzed whether the small-molecule FSHR agonist CAN1405 rescued membrane expression and function of 13 mutant FSHRs leading to premature ovarian failure in women. FSHRs were expressed in HEK-293 cells, and membrane expression was assessed by immunoblotting before and after incubation with CAN1405. Three trafficking defective variants in the ectodomain of the FSHR (A189V, N191I, and D224V) and 3 others located in transmembrane domains (TMD) 3 and 4, and extracellular loop 2 (A462P, P504S, and P519T, respectively) failed to respond (or did it marginally) to CAN1405 by increasing their membrane expression. In contrast, in 7 variants located in the TMD2 (D408Y, A419T, and I423T), TMD6 (A575V, P587H, and F591S), and extracellular loop 3 (L597I), CAN1405 rescued membrane expression of the variants. Functional studies showed that after CAN1405 removal, rescued FSHRs responded to the orthosteric agonist in terms of cAMP-mediated signaling and ERK1/2 phosphorylation. Refined molecular dynamics simulations using the cryo-EM structure of the FSHR revealed key conformational changes and interactions within the TMDs provoked by CAN1405, highlighting potential allosteric binding sites critical for receptor activation. These findings offer a promising therapeutic strategy for treating mutation-provoked FSHR dysfunction and underscore the synergistic potential of computational biophysics in drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Red de Apoyo a la Investigación (RAI), National University of Mexico, Mexico City 04510, Mexico.
- Departamento de Recursos de la Tierra, UAM-Unidad Lerma, Edo. de México 52005, Mexico.
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Cancer Biology, Astellas Pharma, Cambridge, MA 02141, USA.
- CanWell Pharma Inc., Wellesley Hills, MA, 02481, USA.
- RAI, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City14000, Mexico.
ORCID-Profile: Eduardo Jardón-Valadez, Ernesto Ulloa-Pérez, Alfredo Ulloa-Aguirre
Förderung
- Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM, Mexico
- Coordinación de la Investigación Científica (CIC), UNAM, Mexico
- Nanomaterials and Molecular Biophysics academic area of UAM-Lerma
Zitieren
APA
Zariñán, T., Jardón-Valadez, E., Gutiérrez-Sagal, R., Ulloa-Pérez, E., Nataraja, S., Yu, H. N., & Ulloa-Aguirre, A. (2026). Pharmacological rescue of follicle-stimulating hormone receptor mutants. In vitro and in silico studies. Endocrinology, 167(5). https://doi.org/10.1210/endocr/bqag045
Vancouver
Zariñán T, Jardón-Valadez E, Gutiérrez-Sagal R, Ulloa-Pérez E, Nataraja S, Yu HN, et al. Pharmacological rescue of follicle-stimulating hormone receptor mutants. In vitro and in silico studies. Endocrinology. 2026;167(5). doi:10.1210/endocr/bqag045
BibTeX
@article{Zarin2026,
author = {Zariñán, Teresa and Jardón-Valadez, Eduardo and Gutiérrez-Sagal, Rubén and Ulloa-Pérez, Ernesto and Nataraja, Selvaraj and Yu, Henry N and Ulloa-Aguirre, Alfredo},
title = {Pharmacological rescue of follicle-stimulating hormone receptor mutants. In vitro and in silico studies},
journal = {Endocrinology},
year = {2026},
volume = {167},
number = {5},
doi = {10.1210/endocr/bqag045}
}
EUVIMED